Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus
Table 1
Demographic and clinical characteristics of both patients and controls.
Parameters
Controls
Patients
Age (years)
61.14 ± 6.65
64.21 ± 7.18
Sex (men/women)
10/21
16/27
BMI (kg/m2)
26.355 ± 2.247
27.583 ± 3.619
Duration of disease (years)
7.02 ± 5.15
Blood glucose (mg/dL)
88.26 ± 21.21
131.59 ± 33.40
HbA1c (%)
6.34 ± 0.73
Total cholesterol (mg/dL)
165.35 ± 24.38
170.71 ± 27.01
HDL cholesterol (mg/dL)
49.22 ± 10.21
55.20 ± 11.20
LDL cholesterol (mg/dL)
92.54 ± 13.58
96.24 ± 18.91
Triglycerides (mg/dL)
89.65 ± 36.28
94.47 ± 42.42
Serum creatinine (g/dL)
0.75 ± 0.12
0.78 ± 0.15
eGFR (mL/min/1.73 m2)
89.6 ± 14.5
Microalbuminuria (mg/24 h)
9.38 ± 6.67
Systolic blood pressure (mmHg)
132.1 ± 16.2
Diastolic blood pressure (mmHg)
78.6 ± 9.7
Data are mean ± SD. eGFR = estimated glomerular filtration rate calculated using the equation developed in the MDRD (Modification of Diet in Renal Disease) study.
